FrancophonIA/ELRC3.0 huggingface dataset:
English: Reproductive studies in rats and mice have shown delayed date of delivery, prolonged duration of labour and decreased pup survival at dosages approximately 50 times greater than the maximum recommended dosage for humans based on mg/kg.
Estonian: Rottide ja hiirtega läbi viidud reproduktiivsuse uuringutes ilmnesid inimestele soovitatavast maksimumannusest ligikaudu 50 korda suuremate annuste juures (mg/kg skaalal) sünnituse edasilükkumine, sünnitustegevuse pikenemine ja järglaste elulemuse vähenemine.
English: Titanium dioxide (E171) Iron oxide, yellow (E172) Iron oxide, red (E172)
Estonian: Titaandioksiid (E171) Kollane raudoksiid (E172) Punane raudoksiid (E172)
English: Hypochloraemic alkalosis
Estonian: Hüpokloreemiline alkaloos
English: Valsartan Inhibitors of the uptake transporter (rifampicin, ciclosporin) or efflux transporter (ritonavir)
Estonian: Tagasihaarde transporteri inhibiitorid (rifampitsiin, tsüklosporiin) või väljavoolu vahendava transporteri inhibiitorid (ritonaviir)
English: • abnormal coordination
Estonian: • koordinatsioonihäired
English: If hypokalaemia develops during hydrochlorothiazide therapy, Imprida HCT should be discontinued until stable correction of the potassium balance.
Estonian: Kui hüpokaleemia tekib ravi ajal hüdroklorotiasiidiga, tuleb Imprida HCT manustamine lõpetada kuni kaaliumitaseme stabiliseerumiseni.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Imprida HCT in all subsets of the paediatric population in essential hypertension.
Estonian: Euroopa Ravimiamet ei kohusta esitama Imprida HCT'ga läbi viidud uuringute tulemusi laste kõikide alarühmade kohta, kellel esineb primaarne hüpertensioon (vt lõik 4.2. informatsioon kasutamisel pediaatrias).
English: Caution is advised in patients with heart failure and coronary artery disease, particularly at the maximum dose of Imprida HCT, 10 mg/320 mg/25 mg.
Estonian: Ettevaatlik peab olema südamepuudulikkuse ja koronaartõvega patsientide ravimisel, eriti kui kasutatakse Imprida HCT maksimaalset annust 10 mg/320 mg/25 mg.
English: CYP3A4 inducers (anticonvulsant agents [e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone], rifampicin, Hypericum perforatum [St. John's wort])
Estonian: CYP3A4 indutseerijad (antikonvulsandid, [nt karbamasepiin, fenobarbitaal, fenütoiin, fosfenütoiin, primidoon], rifampitsiin, naistepuna)
English: Titanium dioxide (E171) Iron oxide, yellow (E172)
Estonian: Titaandioksiid (E171) Kollane raudoksiid (E172)
English: Impairment of fertility
Estonian: Fertiilsuse vähenemine
English: No dosage adjustment of Imprida HCT is required for patients with mild to moderate renal impairment (GFR ≥30 ml/min/1.73 m
Estonian: Kerge kuni mõõduka neerukahjustusega patsientidel (GFR ≥30 ml/min/1,73 m 2) ei ole vaja Imprida
English: • muscle cramps/weakness/pain
Estonian: • lihaskrambid/-nõrkus/-valu
English: Cases of photosensitivity reactions have been reported with thiazide diuretics (see section 4.8).
Estonian: Tiasiiddiureetikumide kasutamisel on kirjeldatud valgustundlikkusreaktsioonide teket (vt lõik 4.8).
English: The increase in mean AUC is linear and dose proportional in the therapeutic range.
Estonian: Terapeutilise annusevahemiku piirides on keskmise AUC suurenemine lineaarne ja proportsionaalne annusega.
English: This dose is 6 times the maximum recommended human dose on a mg/m basis
Estonian: See annus on 6 korda suurem maksimaalsest inimesele soovitatavast annusest mg/m baasil (arvutused eeldavad suukaudset annust
English: Due to the valsartan component, Imprida HCT is contraindicated in patients with hepatic impairment (see sections 4.2 and 4.3).
Estonian: Valsartaani sisalduse tõttu on Imprida HCT vastunäidustatud maksakahjustusega patsientidel (vt lõigud 4.2 ja 4.3).
English: Amlodipine Others
Estonian: Amlodipiin Muud
English: • sugar in the urine
Estonian: • suhkrusisaldus uriinis
English: Treatment with Imprida HCT should only start after correction of hypokalaemia and any coexisting hypomagnesaemia.
Estonian: Ravi Imprida HCT'ga tohib alustada ainult pärast hüpokaleemia ja samaaegse hüpomagneseemia korrigeerimist.
English: Thiazide diuretics, including hydrochlorothiazide, have been reported to exacerbate or activate systemic lupus erythematosus.
Estonian: Tiasiiddiureetikumide, sh hüdroklorotiasiidi kasutamisel on kirjeldatud süsteemse erütematoosse luupuse ägenemist või aktiveerumist.
English: The bioavailability of thiazide-type diuretics may be increased by anticholinergic agents (e.g. atropine, biperiden), apparently due to a decrease in gastrointestinal motility and the stomach emptying rate.
Estonian: Antikolinergiliste ravimite (nt atropiin, biperideen) toimel võib tiasiidi-tüüpi diureetikumide biosaadavus suureneda seedetrakti motoorika vähenemise ja mao tühjenemise aeglustumise tõttu.
English: Multipacks of 280 tablets, comprising 20 cartons, each containing 14 tablets.
Estonian: 280 tabletist koosnevad multipakendid, igaühes 20 pappkarpi, millest igaüks sisaldab 14 tabletti.
English: 98 film-coated tablets
Estonian: 98 õhukese polümeerikattega tabletti
English: Thiazide diuretics can precipitate new onset hypokalaemia or exacerbate preexisting hypokalaemia.
Estonian: Tiasiiddiureetikumid võivad viia hüpokaleemia esmase avaldumise või olemasoleva hüpokaleemia süvenemiseni.
English: These doses in rats (200 and 600 mg/kg/day) are approximately 6 and 18 times the maximum recommended human dose on a mg/m basis (calculations assume an oral dose of
Estonian: Need rottide annused (200...600 mg/kg päevas) on ligikaudu 6 ja 18 korda suuremad maksimaalsest inimesele soovitatud annusest mg/m alusel (arvutustes eeldatakse, et suukaudne annus on 320 mg päevas ja patsiendi kehakaal 60 kg).
English: • swelling, reddening and pain along a vein
Estonian: • turse, punetus ja valu piki veeni kulgu
English: Amlodipine is unlikely to be removed by haemodialysis.
Estonian: Amlodipiin ei ole tõenäoliselt hemodialüüsitav.
English: Systemic lupus erythematosus
Estonian: Süsteemne erütematoosne luupus
English: • confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)
Estonian: • segasus, väsimus, lihastõmblused ja -spasmid, kiire hingamine (hüpokloreemiline alkaloos)
English: • tingling or numbness
Estonian: • surisemine või tuimus
English: • frequent urination
Estonian: • sagenenud urineerimine
English: This is a disease in which the adrenal glands make too much of the hormone aldosterone If this applies to you, the use of Imprida HCT is not recommended.
Estonian: See on haigus, mille puhul neerupealised toodavad liiga palju aldosterooniks nimetatud hormooni.
English: Administration of valsartan to patients with hypertension results in a drop in blood pressure without affecting pulse rate.
Estonian: Valsartaani manustamisel hüpertensiooniga patsientidele langeb vererõhk, kuid pulsisagedus ei muutu.
English: • liver disorder which can occur together with yellow skin and eyes, or dark-coloured urine
Estonian: • maksatalitluse häire, millega võib kaasneda naha ja silmavalgete kollasus või uriini tumenemine
English: • weakness
Estonian: • nõrkus
English: HOW TO TAKE IMPRIDA HCT
Estonian: KUIDAS IMPRIDA HCT'D VÕTTA
English: • spontaneous bleeding
Estonian: • spontaanne veritsus
English: Iodine contrasting agents
Estonian: Joodi sisaldavad kontrastained
English: 280 x 1 film-coated tablet (unit dose)
Estonian: 280 x 1 õhukese polümeerikattega tablett (üheannuseline)
English: • high level of sugar in the blood
Estonian: • kõrge kusihappesisaldus veres
English: 28 film-coated tablets
Estonian: 28 õhukese polümeerikattega tabletti
English: Hydrochlorothiazide is excreted in human milk in small amounts.
Estonian: Hüdroklorotiasiid eritub vähesel määral inimese rinnapiima.
English: Medicinal products affecting serum sodium level
Estonian: Seerumi kaaliumisisaldust mõjutavad ravimid
English: The pharmacokinetics of amlodipine are not significantly influenced by renal impairment.
Estonian: Neerukahjustus ei mõjuta oluliselt amlodipiini farmakokineetikat.
English: The use of AIIRAs is contraindicated during the second and third trimesters of pregnancy (see sections 4.3 and 4.4).
Estonian: Ravi angiotensiin II retseptori antagonistidega (AIIRA) on vastunäidustatud raseduse teisel ja kolmandal trimestril (vt lõigud 4.3 ja 4.4).
English: 56 film-coated tablets
Estonian: 56 õhukese polümeerikattega tabletti
English: Renal failure and impairment
Estonian: Neerupuudulikkus ja -kahjustus
English: Non-depolarising skeletal muscle relaxants (e.g. tubocurarine)
Estonian: Mittedepolariseerivad lihasrelaksandid (nt tubokurariin)
English: Due to the valsartan component, Imprida HCT is contraindicated in patients with severe hepatic impairment (see section 4.3).
Estonian: Valsartaani sisalduse tõttu on Imprida HCT vastunäidustatud raske maksakahjustusega patsientidel (vt lõik 4.3).
English: • vision disorder
Estonian: • nägemishäire
English: • inflammation of the stomach lining or of the pancreas, gingival overgrowth, abnormal liver function test
Estonian: • maolimaskesta- või kõhunäärmepõletik, igemete vohamine, kõrvalekalded maksafunktsiooni testides
English: 30 film-coated tablets
Estonian: 30 õhukese polümeerikattega tabletti
English: Thiazides, including hydrochlorothiazide, potentiate the action of curare derivatives.
Estonian: Tiasiidid (sh hüdroklorotiasiid) võivad tugevdada kuraare derivaatide toimet.
English: A total of 2,271 patients with moderate to severe hypertension (mean baseline systolic/diastolic blood pressure was 170/107 mmHg) received treatments of amlodipine/valsartan/hydrochlorothiazide 10 mg/320 mg/25 mg, valsartan/hydrochlorothiazide 320 mg/25 mg, amlodipine/valsartan 10 mg/320 mg, or hydrochlorothiazide/amlodipine 25 mg/10 mg. At study initiation patients were assigned lower doses of their treatment combination and were titrated to their full treatment dose by week 2.
Estonian: Kokku said 2271 mõõduka kuni raske hüpertensiooniga (keskmine ravieelne süstoolne/diastoolne vererõhk oli 170/107 mmHg) patsienti raviks amlodipiini/valsartaani/hüdroklorotiasiidi annuses 10 mg/320 mg/25 mg, valsartaani/ hüdroklorotiasiidi annuses 320 mg/25 mg, amlodipiini/valsartaani annuses 10 mg/320 mg või hüdroklorotiasiidi/amlodipiini annuses 25 mg/10 mg.
English: Amlodipine/valsartan/hydrochlorothiazide
Estonian: Amlodipiin/valsartaan/hüdroklorotiasiid
English: Amlodipine/Valsartan/Hydrochlorothiazide
Estonian: Amlodipiin/Valsartaan/Hüdroklorotiasiid
English: These doses in rats (600 mg/kg/day) are approximately 18 times the maximum recommended human dose on a mg/m basis (calculations assume an oral dose of
Estonian: Need rottide annused (600 mg/kg päevas) on ligikaudu 18 korda suuremad maksimaalsest inimesele soovitatud annusest mg/m alusel (arvutustes eeldatakse, et suukaudne annus on 320 mg päevas ja patsiendi kehakaal
English: Grapefruit and grapefruit juice should not be consumed by people who are taking Imprida HCT.
Estonian: Inimesed, kes võtavad Imprida HCT'd, ei tohiks tarvitada greipfruuti ega greipfruudimahla.
English: Multipack comprising 4 cartons, each containing 70 tablets.
Estonian: 4 karbist koosneva multipakendi osa, igaühes 70 tabletti.
English: Frequency Imprida HCT
Estonian: Sagedus Imprida
English: Cellulose microcrystalline Crospovidone Silica, colloidal anhydrous Magnesium stearate
Estonian: Mikrokristalne tselluloos Krospovidoon
English: • low blood pressure on standing up
Estonian: • vererõhu langus püsti tõusmisel
English: if you have or have had heart failure or coronary artery disease, particularly if you are taking the maximum dose of Imprida HCT (10 mg/320 mg/25 mg) if your doctor has told you that you have a narrowing of the valves in your heart (called “aortic or mitral stenosis”) or that the thickness of your heart muscle is abnormally increased (called “obstructive hypertrophic cardiomyopathy”).
Estonian: kui arst on teile öelnud, et teil esineb südameklappide ahenemine (nimetatakse „aordi- või mitraalstenoosiks”) või et teie südamelihas on haiguslikult paksenenud (nimetatakse „obstruktiivseks hüpertroofiliseks kardiomüopaatiaks”).
English: Valsartan
Estonian: Valsartaan
English: Renal failure acute
Estonian: Äge neerupuudulikkus
English: Co-administration of thiazide diuretics, including hydrochlorothiazide, may increase the incidence of hypersensitivity reactions to allopurinol.
Estonian: Tiasiiddiureetikumide, sh hüdroklorotiasiidi samaaegne manustamine võib suurendada allopurinooli ülitundlikkusreaktsioonide esinemissagedust.
English: • pale skin, tiredness, breathlessness, dark-coloured urine (haemolytic anaemia, abnormal breakdown of red blood cells either in the blood vessels or elsewhere in the body)
Estonian: • kahvatu nahk, väsimus, hingamisraskus, tumedat värvi uriin (hemolüütiline aneemia,
English: • inflammation of blood vessels with symptoms such as rash, purplish-red spots, fever (vasculitis)
Estonian: • veresoonte põletik koos sümptomitega nagu lööve, lillakaspunased laigud, palavik (vaskuliit)
English: Thiazide diuretics, including hydrochlorothiazide, may enhance the hyperglycaemic effect of diazoxide.
Estonian: Tiasiiddiureetikumide, sh hüdroklorotiasiidi mõjul võib suureneda diasoksiini hüperglükeemiline toime.
English: • stiffness
Estonian: • kõhukinnisus
English: Medicinal products affecting serum potassium level
Estonian: Seerumi naatriumisisaldust mõjutavad ravimid
English: Thiazide-induced hypokalaemia or hypomagnesaemia may occur as undesirable effects, favouring the onset of digitalis-induced cardiac arrhythmias.
Estonian: Digitaalise glükosiidid Tiasiididest põhjustatud hüpokaleemia või hüpomagneseemia võivad kõrvaltoimena soodustada digitaalisest põhjustatud südame rütmihäirete teket.
English: • palpitations
Estonian: • palavik
English: • vomiting
Estonian: • oksendamine
English: Absorption: Following oral administration of valsartan alone, peak plasma concentrations of valsartan are reached in 2-4 hours.
Estonian: Imendumine: Pärast valsartaani suukaudset manustamist saabub ravimi maksimaalne kontsentratsioon plasmas 2...4 tunni jooksul.
English: Serum electrolyte changes
Estonian: Seerumi elektrolüütide sisalduse muutused
English: Hypomagnesaemia
Estonian: Hüpomagneseemia
English: • heart attack
Estonian: • südameinfarkt
English: Imprida HCT 10 mg/320 mg/25 mg film-coated tablets: Each film-coated tablet contains 10 mg amlodipine (as amlodipine besylate), 320 mg valsartan, and 25 mg hydrochlorothiazide.
Estonian: Imprida HCT 10 mg/320 mg/25 mg õhukese polümeerikattega tabletid: Iga õhukese polümeerikattega tablett sisaldab 10 mg amlodipiini (amlodipiinbesülaadina), 320 mg valsartaani ja 25 mg hüdroklorotiasiidi.
English: Rash
Estonian: Ravi
English: It may be necessary to check the amount of potassium in your blood at regular intervals.
Estonian: Vajalikuks võib osutuda vere kaaliumisisalduse regulaarne kontroll.
English: • weight increase
Estonian: • suurenenud lihasjäikus
English: Diarrhoea
Estonian: Pankreatiit
English: Ask your doctor or pharmacist for advice before taking any medicine.
Estonian: Enne ravimi kasutamist pidage nõu oma arsti või apteekriga.
English: CARTON OF UNIT PACK
Estonian: ÜKSIKPAKENDI KARP
English: Hypokalaemia
Estonian: Hüpokaleemia
English: • muscle spasm
Estonian: • lihasvalu
English: • itchy rash and other types of rash
Estonian: • sügelev lööve ja muud tüüpi lööbed
English: Kidney transplantation
Estonian: Neerusiirdamine
English: HOW TO STORE IMPRIDA HCT
Estonian: KUIDAS IMPRIDA HCT'D SÄILITADA
English: Hypercalcaemia
Estonian: Hüperkaltseemia
English: • liver disorders which can occur together with yellow skin and eyes, or dark-coloured urine
Estonian: • maksatalitluse häired, millega võib kaasneda naha ja silmavalgete kollasus või uriini tumenemine (hemolüütiline aneemia)
English: • cough
Estonian: • köha
English: Hyponatraemia
Estonian: Hüponatreemia
English: Reversible increases in serum lithium concentrations and toxicity have been reported during concurrent use of ACE inhibitors and thiazides such as hydrochlorothiazide.
Estonian: AKE inhibiitorite ja tiasiidide (nagu hüdroklorotiasiidi) samaaegsel kasutamisel on täheldatud seerumi liitiumisisalduse pöörduvat suurenemist ning sellega kaasnevat toksilisust.
English: Imprida HCT 10 mg/320 mg/25 mg film-coated tablets
Estonian: Imprida HCT 10 mg/320 mg/25 mg õhukese polümeerikattega tabletid
English: • increase of urea nitrogen, creatinine and uric acid in the blood
Estonian: • uurealämmastiku, kreatiniini ja kusihappe taseme tõus veres
English: Hydrochlorothiazide
Estonian: Hüdroklorotiasiid
English: The site of action of thiazide diuretics is primarily in the renal distal convoluted tubule.
Estonian: Tiasiiddiureetikumide põhiline toimekoht on distaalsed neerutorukesed.
English: • spinning sensation
Estonian: • meeleolu kõikumine
English: Change of bowel habit
Estonian: • naha värvuse muutus
English: fever (erythema multiforme)
Estonian: naha irdumist, palavikku (multiformne erüteem)
English: Micturition disorder
Estonian: Seedetrakti häired
English: Simvastatin
Estonian: Simvastatiin
English: • fast heart beat
Estonian: • kiire südametegevus
English: • abdominal discomfort
Estonian: • maitsetundlikkuse häired
English: • constipation
Estonian: • väsimus
English: EU/1/09/570/043 280 film-coated tablets
Estonian: EU/1/09/570/043 280 õhukese polümeerikattega tabletti
English: BLISTERS
Estonian: Pearinglus
English: • trembling
Estonian: Treemor
English: • medicines that may reduce the amount of potassium in your blood, such as diuretics (water tablets), corticosteroids, laxatives, amphotericin or penicillin G; medicines to increase blood pressure such as adrenaline or noradrenaline; medicines used for HIV/AIDS (e.g. ritonavir, indinavir, nelfinavir); medicines used to treat fungal infections (e.g. ketoconazole, itraconazole); medicines used for oesophageal ulceration and inflammation (carbenoxolone); medicines used to relieve pain or inflammation, especially non-steroidal anti-inflammatory agents (NSAIDs), including selective cyclooxygenase-2 inhibitors (Cox-2 inhibitors);
Estonian: • ravimid, mille toimel võib väheneda vere kaaliumisisaldus, näiteks diureetikumid (vett väljaviivad tabletid), kortikosteroidid, lahtistid, amfoteritsiin või penitsilliin G; vererõhku tõstvad ravimid nagu adrenaliin või noradrenaliin;
English: EU/1/09/570/031 280 film-coated tablets
Estonian: EU/1/09/570/031 280 õhukese polümeerikattega tabletti
English: • purple skin patches
Estonian: • punakaslillad nahalaigud
English: Renal dysfunction
Estonian: Neerufunktsiooni häire
English: • increase of lipids in the blood
Estonian: • vere lipiidide sisalduse suurenemine
English: EU/1/09/570/055 280 film-coated tablets
Estonian: EU/1/09/570/055 280 õhukese polümeerikattega tabletti
English: • iodine contrast media (agents used for imaging examinations); medicines for the treatment of diabetes (oral agents such as metformin or insulins); medicines for the treatment of gout, such as allopurinol; medicines that may increase blood sugar levels (beta blockers, diazoxide);
Estonian: • joodi sisaldavad kontrastained (ained, mida kasutatakse piltdiagnostika uuringuteks); suhkurtõve ravimid (suukaudsed ravimid [nagu metformiin] või insuliinid);
English: • tiredness
Estonian: • iiveldus
English: EU/1/09/570/038 28 film-coated tablets
Estonian: EU/1/09/570/038 28 õhukese polümeerikattega tabletti
English: Imprida HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Estonian: Imprida HCT 10 mg/320 mg/25 mg õhukese polümeerikattega tabletid amlodipiin/valsartaan/hüdroklorotiasiid
English: EU/1/09/570/026 28 film-coated tablets
Estonian: EU/1/09/570/026 28 õhukese polümeerikattega tabletti
English: • nausea
Estonian: • tursed
English: EU/1/09/570/004 56 film-coated tablets
Estonian: EU/1/09/570/004 56 õhukese polümeerikattega tabletti
English: EU/1/09/570/016 56 film-coated tablets
Estonian: EU/1/09/570/016 56 õhukese polümeerikattega tabletti
English: Component of a multipack comprising 4 cartons, each containing 70 tablets.
Estonian: 70 õhukese polümeerikattega tabletti 4 karbist koosneva multipakendi üks osa, igaühes 70 tabletti.
English: EU/1/09/570/007 280 film-coated tablets
Estonian: EU/1/09/570/007 280 õhukese polümeerikattega tabletti
English: The other ingredients are cellulose microcrystalline; crospovidone; silica, colloidal anhydrous; magnesium stearate; hypromellose, macrogol 4000, talc, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Estonian: Abiained on mikrokristalne tselluloos; krospovidoon; kolloidne veevaba ränidioksiid; magneesiumstearaat; hüpromelloos, makrogool 4000, talk, titaandioksiid (E171), kollane raudoksiid (E172), punane raudoksiid (E172).
English: Pollakiuria
Estonian: Pollakisuuria
English: Amantadine
Estonian: Lööve
English: EU/1/09/570/042 98 film-coated tablets
Estonian: EU/1/09/570/042 98 õhukese polümeerikattega tabletti
English: What Imprida HCT looks like and contents of the pack Imprida HCT 10 mg/320 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VFL” on the other side.
Estonian: Kuidas Imprida HCT välja näeb ja pakendi sisu Imprida HCT 10 mg/320 mg/25 mg õhukese polümeerikattega tabletid on pruunikaskollased, ovaalsed tabletid, mille ühel poolel on kiri „NVR” ja teisel „VFL”.
English: Imprida HCT 5 mg/160 mg/25 mg film-coated tablets: Each film-coated tablet contains 5 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 25 mg hydrochlorothiazide.
Estonian: Imprida HCT 5 mg/160 mg/25 mg õhukese polümeerikattega tabletid: Iga õhukese polümeerikattega tablett sisaldab 5 mg amlodipiini (amlodipiinbesülaadina), 160 mg valsartaani ja 25 mg hüdroklorotiasiidi.
English: What Imprida HCT looks like and contents of the pack Imprida HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Estonian: Kuidas Imprida HCT välja näeb ja pakendi sisu Imprida HCT 5 mg/160 mg/12,5 mg õhukese polümeerikattega tabletid on valged, ovaalsed tabletid, mille ühel poolel on kiri „NVR” ja teisel „VCL”.
English: EU/1/09/570/006 98 film-coated tablets
Estonian: EU/1/09/570/006 98 õhukese polümeerikattega tabletti
English: EU/1/09/570/054 98 film-coated tablets
Estonian: EU/1/09/570/054 98 õhukese polümeerikattega tabletti
English: Imprida HCT 5 mg/160 mg/12.5 mg film-coated tablets: Each film-coated tablet contains 5 mg amlodipine (as amlodipine besylate), 160 mg valsartan and 12.5 mg hydrochlorothiazide.
Estonian: Imprida HCT 5 mg/160 mg/12,5 mg õhukese polümeerikattega tabletid: Iga õhukese polümeerikattega tablett sisaldab 5 mg amlodipiini (amlodipiinbesülaadina), 160 mg valsartaani ja 12,5 mg hüdroklorotiasiidi.
English: EU/1/09/570/040 56 film-coated tablets
Estonian: EU/1/09/570/040 56 õhukese polümeerikattega tabletti
English: Imprida HCT 10 mg/160 mg/25 mg film-coated tablets: Each film-coated tablet contains 10 mg amlodipine (as amlodipine besylate), 160 mg valsartan, and 25 mg hydrochlorothiazide.
Estonian: Imprida HCT 10 mg/160 mg/25 mg õhukese polümeerikattega tabletid: Iga õhukese polümeerikattega tablett sisaldab 10 mg amlodipiini (amlodipiinbesülaadina), 160 mg valsartaani ja 25 mg hüdroklorotiasiidi.
English: EU/1/09/570/001 14 film-coated tablets
Estonian: EU/1/09/570/001 14 õhukese polümeerikattega tabletti
English: • low level of potassium in the blood
Estonian: • madal kaaliumisisaldus veres
English: White, ovaloid, biconvex tablets with bevelled edge, debossed “NVR” on one side and “VCL” on the other side.
Estonian: Valged, ovaalsed, kaldu servaga kaksikkumerad tabletid, mille ühele poolele on pressitud „NVR“ ja teisele „VCL“.
English: Each tablet contains 10 mg amlodipine (as amlodipine besylate), 320 mg valsartan and 25 mg hydrochlorothiazide.
Estonian: Üks tablett sisaldab 10 mg amlodipiini (amlodipiinbesülaadina), 320 mg valsartaani ja 25 mg hüdroklorotiasiidi.
English: What Imprida HCT looks like and contents of the pack Imprida HCT 5 mg/160 mg/25 mg film-coated tablets are yellow, oval tablets with “NVR” on one side and “VEL” on the other side.
Estonian: Kuidas Imprida HCT välja näeb ja pakendi sisu Imprida HCT 5 mg/160 mg/25 mg õhukese polümeerikattega tabletid on kollased, ovaalsed tabletid, mille ühel poolel on kiri „NVR” ja teisel „VEL”.
English: Hyperuricaemia
Estonian: Hüperurikeemia